Pic: Getty Images
Health & Biotech
The S&P/ASX 200 Health Care (ASX:XHJ) Index rose 2.89% in November and is up 9.54% YTD.
For the year, the XHJ trails the benchmark S&P/ASX 200 Index, which rose 3.79% in November and has risen 15.07% YTD.
On November 26, human and animal health cryogenic services company Vitrafy Life Sciences (ASX:VFY) and nerve-repair biotech Renerve (ASX:RNV) hit the ASX boards with the first IPOs in the ASX healthcare sector since Blinklab (ASX:BB1) in April.
Morgans healthcare analyst Scott Power told Stockhead last week that momentum is returning to the ASX healthcare sector.
“There are more capital raisings coming through and money out there looking for a home and we’ve had a couple of IPOs in November,” he said.
Power added it was worth noting there appeared to be more ASX healthcare companies with gains in November than losses.
“The market is rewarding companies that are announcing positive news.”
| COMPANY | PRICE | 1 MONTH RETURN % | MARKET CAP | |
|---|---|---|---|---|
| PAR | Paradigm Biopharmaceuticals | $0.515 | 151.2 | $179,890,542 |
| IMR | Imricor Med Sys | $1.160 | 84.1 | $313,403,889 |
| IRX | Inhalerx Limited | $0.042 | 75.0 | $8,869,630 |
| ILA | Island Pharma | $0.195 | 69.6 | $30,427,938 |
| CMB | Cambium Bio Limited | $0.650 | 58.5 | $7,755,154 |
| PAB | Patrys Limited | $0.005 | 50.0 | $9,258,513 |
| SIG | Sigma Health Ltd | $2.890 | 47.4 | $4,536,587,855 |
| DVL | Dorsavi Ltd | $0.014 | 40.0 | $10,237,331 |
| HIQ | Hitiq Limited | $0.041 | 36.7 | $14,507,644 |
| MSB | Mesoblast Limited | $1.770 | 35.1 | $1,986,704,358 |
| SHG | Singular Health | $0.110 | 34.1 | $26,676,635 |
| AVE | Avecho Biotech Ltd | $0.004 | 33.3 | $12,677,188 |
| 1AI | Algorae Pharma | $0.008 | 33.3 | $13,499,158 |
| SNT | Syntara Limited | $0.056 | 33.3 | $76,895,935 |
| BP8 | Bph Global Ltd | $0.004 | 33.3 | $1,586,566 |
| ATH | Alterity Therapeutics | $0.004 | 33.3 | $21,281,344 |
| OCC | Orthocell Limited | $0.810 | 32.8 | $193,682,686 |
| AVH | Avita Medical | $3.940 | 30.0 | $275,315,538 |
| NTI | Neurotech Intl | $0.070 | 29.6 | $72,423,534 |
| PME | Pro Medicus Limited | $251.890 | 28.6 | $25,934,532,783 |
| MDR | Medadvisor Limited | $0.310 | 24.0 | $170,923,347 |
| CDX | Cardiex Limited | $0.100 | 22.0 | $29,417,457 |
| CC5 | Clever Culture | $0.017 | 21.4 | $29,889,622 |
| RHT | Resonance Health | $0.057 | 21.3 | $26,198,120 |
| CVB | Curvebeam Ai Limited | $0.110 | 19.6 | $34,936,542 |
| PGC | Paragon Care Limited | $0.495 | 19.3 | $819,376,168 |
| ALC | Alcidion Group Ltd | $0.063 | 18.9 | $84,606,020 |
| EMD | Emyria Limited | $0.038 | 18.8 | $15,784,797 |
| SPL | Starpharma Holdings | $0.115 | 18.6 | $48,082,309 |
| SOM | SomnoMed Limited | $0.385 | 18.5 | $83,201,677 |
| IMM | Immutep Ltd | $0.325 | 18.2 | $465,461,711 |
| ARX | Aroa Biosurgery | $0.705 | 17.5 | $243,154,680 |
| RAD | Radiopharm | $0.028 | 16.7 | $60,842,901 |
| TRU | Truscreen | $0.022 | 15.8 | $12,157,005 |
| TLX | Telix Pharmaceutical | $24.740 | 15.3 | $7,959,748,253 |
| MYX | Mayne Pharma Ltd | $5.100 | 15.1 | $406,655,097 |
| CYC | Cyclopharm Limited | $1.680 | 15.1 | $186,709,908 |
| ECS | ECS Botanics Holding | $0.018 | 12.5 | $23,193,892 |
| BMT | Beamtree Holdings | $0.255 | 10.9 | $73,889,161 |
| PNV | Polynovo Limited | $2.200 | 8.9 | $1,492,032,543 |
| SDI | SDI Limited | $1.105 | 8.3 | $131,346,411 |
| CTQ | Careteq Limited | $0.013 | 8.3 | $3,082,543 |
| ACW | Actinogen Medical | $0.027 | 8.0 | $83,232,035 |
| ANN | Ansell Limited | $33.160 | 7.3 | $4,826,367,551 |
| SHL | Sonic Healthcare | $28.570 | 7.2 | $13,734,749,588 |
| CAN | Cann Group Ltd | $0.047 | 6.8 | $22,532,564 |
| COH | Cochlear Limited | $304.240 | 6.7 | $20,138,897,670 |
| EBO | Ebos Group Ltd | $34.650 | 5.8 | $6,770,965,739 |
| FPH | Fisher & Paykel Healthcare | $34.520 | 4.7 | $19,840,328,102 |
| HMD | Heramed Limited | $0.023 | 4.5 | $18,113,933 |
| REG | Regis Healthcare Ltd | $6.680 | 4.4 | $1,973,183,243 |
| BOT | Botanix Pharma Ltd | $0.360 | 4.3 | $654,285,755 |
| SNZ | Summerset Grp Hldgs | $11.740 | 4.2 | $2,780,330,478 |
| RMD | ResMed Inc. | $38.400 | 3.9 | $23,574,481,657 |
| CBL | Control Bionics | $0.063 | 3.3 | $15,596,176 |
| OIL | Optiscan Imaging | $0.165 | 3.1 | $137,831,232 |
| PSQ | Pacific Smiles Grp | $1.950 | 2.6 | $311,184,779 |
| CGS | Cogstate Ltd | $1.000 | 2.6 | $172,744,894 |
| MVF | Monash IVF Group Ltd | $1.200 | 2.6 | $467,561,808 |
| NAN | Nanosonics Limited | $3.260 | 1.9 | $986,225,760 |
| NEU | Neuren Pharmaceut. | $12.470 | 1.8 | $1,614,311,988 |
| OCA | Oceania Healthc Ltd | $0.650 | 1.6 | $470,750,170 |
| EMV | Emvision Medical | $1.980 | 1.5 | $169,322,739 |
| CAJ | Capitol Health | $0.365 | 1.4 | $389,339,161 |
| ALA | Arovella Therapeutic | $0.190 | 1.3 | $201,283,821 |
| LTP | Ltr Pharma Limited | $1.260 | 0.8 | $106,834,203 |
| RHC | Ramsay Health Care | $39.590 | 0.8 | $9,071,869,818 |
| CSL | CSL Limited | $282.220 | 0.2 | $138,086,027,351 |
| OSL | Oncosil Medical | $0.008 | 0.0 | $35,792,641 |
| ADR | Adherium Ltd | $0.011 | 0.0 | $8,344,380 |
| IIQ | Inoviq Ltd | $0.460 | 0.0 | $51,302,283 |
| MAP | Microba Lifesciences | $0.170 | 0.0 | $76,134,836 |
| HXL | Hexima | $0.014 | 0.0 | $2,255,035 |
| TD1 | Tali Digital Limited | $0.001 | 0.0 | $3,295,156 |
| VTI | Vision Tech Inc | $0.120 | 0.0 | $6,604,376 |
| RSH | Respiri Limited | $0.077 | 0.0 | $99,404,607 |
| MDC | Medlab Clinical Ltd | $6.600 | 0.0 | $15,071,113 |
| GTG | Genetic Technologies | $0.039 | 0.0 | $5,671,273 |
| EPN | Epsilon Healthcare | $0.024 | 0.0 | $7,208,496 |
| ENL | Enlitic Inc. | $0.064 | 0.0 | $36,837,396 |
| AHI | Advanced Health | $0.092 | 0.0 | $25,355,783 |
| VIT | Vitura Health Ltd | $0.099 | 0.0 | $57,583,653 |
| AVR | Anteris Technologies | $10.130 | -0.7 | $214,146,336 |
| RCE | Recce Pharmaceutical | $0.440 | -1.1 | $102,023,511 |
| IMC | Immuron Limited | $0.077 | -1.3 | $17,644,198 |
| HGV | Hygrovest Limited | $0.051 | -1.9 | $10,725,841 |
| AFP | AFT Pharmaceuticals | $2.730 | -2.2 | $286,284,890 |
| IDX | Integral Diagnostics | $2.920 | -2.3 | $680,829,411 |
| PYC | PYC Therapeutics | $1.850 | -2.6 | $863,224,278 |
| NSB | Neuroscientific | $0.036 | -2.7 | $5,205,775 |
| 1AD | Adalta Limited | $0.018 | -2.7 | $11,366,245 |
| ACL | Au Clinical Labs | $3.470 | -2.8 | $702,636,099 |
| ANR | Anatara Ls Ltd | $0.057 | -3.4 | $11,849,942 |
| VBS | Vectus Biosystems | $0.077 | -3.8 | $4,100,505 |
| ONE | Oneview Healthcare | $0.318 | -3.8 | $236,770,767 |
| PEB | Pacific Edge | $0.125 | -3.8 | $101,489,497 |
| CUV | Clinuvel Pharmaceuticals | $13.150 | -4.2 | $655,294,301 |
| GSS | Genetic Signatures | $0.675 | -4.3 | $153,273,709 |
| VLS | Vita Life Sciences.. | $2.010 | -4.3 | $113,023,954 |
| BDX | Bcaldiagnostics | $0.100 | -4.8 | $35,866,428 |
| PTX | Prescient Ltd | $0.039 | -4.9 | $31,407,472 |
| NC6 | Nanollose Limited | $0.019 | -5.0 | $3,268,121 |
| NUZ | Neurizon Therapeutic | $0.185 | -5.1 | $90,965,567 |
| CU6 | Clarity Pharma | $6.410 | -5.2 | $2,036,544,917 |
| AHC | Austco Healthcare | $0.245 | -5.8 | $89,194,911 |
| DOC | Doctor Care Anywhere | $0.065 | -5.8 | $23,831,746 |
| EYE | Nova EYE Medical Ltd | $0.155 | -6.1 | $35,504,418 |
| PIQ | Proteomics Int Lab | $0.680 | -6.2 | $89,081,848 |
| OSX | Osteopore Limited | $0.038 | -6.3 | $4,380,043 |
| PER | Percheron | $0.074 | -6.3 | $80,470,385 |
| COV | Cleo Diagnostics | $0.340 | -6.8 | $27,744,000 |
| GLH | Global Health Ltd | $0.135 | -6.9 | $7,836,687 |
| ZLD | Zelira Therapeutics | $0.650 | -7.1 | $7,375,651 |
| ZLD | Zelira Therapeutics | $0.650 | -7.1 | $7,375,651 |
| IPD | Impedimed Limited | $0.051 | -7.3 | $103,201,397 |
| RHY | Rhythm Biosciences | $0.092 | -8.0 | $26,090,901 |
| UBI | Universal Biosensors | $0.115 | -8.0 | $34,277,755 |
| LGP | Little Green Pharma | $0.110 | -8.3 | $33,316,029 |
| CYP | Cynata Therapeutics | $0.215 | -8.5 | $38,872,273 |
| FRE | Firebrickpharma | $0.052 | -8.8 | $10,925,642 |
| NYR | Nyrada Inc. | $0.100 | -9.1 | $20,962,537 |
| RAC | Race Oncology Ltd | $1.330 | -9.2 | $231,037,922 |
| AT1 | Atomo Diagnostics | $0.019 | -9.5 | $12,144,844 |
| AGN | Argenica | $0.695 | -9.7 | $89,024,527 |
| OPT | Opthea Limited | $0.720 | -10.0 | $837,144,340 |
| CHM | Chimeric Therapeutic | $0.009 | -10.0 | $8,956,267 |
| DXB | Dimerix Ltd | $0.350 | -10.3 | $195,241,754 |
| TRP | Tissue Repair | $0.260 | -10.3 | $15,720,859 |
| NXS | Next Science Limited | $0.130 | -10.3 | $37,980,830 |
| CTE | Cryosite Limited | $0.850 | -10.5 | $41,488,129 |
| PCK | Painchek Ltd | $0.028 | -10.9 | $45,843,312 |
| AYA | Artryalimited | $0.440 | -11.1 | $39,889,852 |
| EBR | EBR Systems | $0.905 | -11.3 | $334,189,841 |
| LDX | Lumos Diagnostics | $0.031 | -11.4 | $23,118,561 |
| MVP | Medical Developments | $0.420 | -11.6 | $47,316,496 |
| TRI | Trivarx Ltd | $0.015 | -11.8 | $6,855,580 |
| RGT | Argent Biopharma Ltd | $0.270 | -12.9 | $14,653,513 |
| HLS | Healius | $1.380 | -12.9 | $1,012,955,316 |
| M7T | Mach7 Tech Limited | $0.365 | -13.1 | $88,052,982 |
| CMP | Compumedics Limited | $0.265 | -13.1 | $48,699,074 |
| 4DX | 4DMedical Limited | $0.460 | -14.0 | $189,164,840 |
| BIT | Biotron Limited | $0.017 | -15.0 | $15,340,507 |
| IMU | Imugene Limited | $0.038 | -15.6 | $290,094,115 |
| IDT | IDT Australia Ltd | $0.105 | -16.0 | $45,133,396 |
| ICR | Intelicare Holdings | $0.010 | -16.7 | $4,861,881 |
| ACR | Acrux Limited | $0.043 | -17.3 | $12,500,825 |
| EOF | Ecofibre Limited | $0.038 | -17.4 | $14,397,208 |
| TRJ | Trajan Group Holding | $1.000 | -18.7 | $152,260,291 |
| UCM | Uscom Limited | $0.032 | -22.0 | $8,015,264 |
| ATX | Amplia Therapeutics | $0.088 | -23.5 | $31,525,405 |
| MX1 | Micro-X Limited | $0.055 | -24.7 | $31,988,207 |
| IVX | Invion Ltd | $0.150 | -25.0 | $10,225,067 |
| AHX | Apiam Animal Health | $0.390 | -25.0 | $71,183,497 |
| AGH | Althea Group | $0.036 | -25.0 | $14,591,968 |
| IXC | Invex Ther | $0.067 | -25.6 | $5,035,308 |
| CSX | Cleanspace Holdings | $0.360 | -26.5 | $28,070,885 |
| NOX | Noxopharm Limited | $0.099 | -26.7 | $28,931,557 |
| IBX | Imagion Biosys Ltd | $0.038 | -26.9 | $1,635,469 |
| MEM | Memphasys Ltd | $0.005 | -28.6 | $8,815,407 |
| IME | Imexhs Limited | $0.320 | -28.9 | $14,598,421 |
| VFX | Visionflex Group Ltd | $0.004 | -30.0 | $11,743,636 |
| EZZ | EZZ Life Science | $2.530 | -31.1 | $116,780,246 |
| FCG | Freedom Care Group | $0.037 | -71.5 | $883,705 |
Paradigm Biopharmaceuticals (ASX:PAR) topped the winners list for the sector in November, rising 151% for the month after the US FDA successfully concluded a 30-day review period for the biotech’s phase III pivotal clinical trial protocol of repurposed pentosan polysulfate sodium (Zilosul) to treat knee osteoarthritis (OA), clearing the way for a start date in Q1 CY25.
Imricor Medical Systems (ASX:IMR) was up ~84.1% in November after announcing it had conducted the first case for atrial flutter ablation in the interventional cardiac magnetic resonance (iCMR) lab at the Lausanne University Hospital (CHUV) in Switzerland, adding a third site to its VISABL-AFL clinical trial supporting US FDA approval of its products.
Imricor is the only company in the world that provides MRI-compatible consumable devices, such as single-use ablation catheters, required to perform cardiac ablations in an iCMR lab. The company also announced in November it had inked a licence agreement with ADIS, a Swiss-based software company, to integrate AI modules into Imricor’s NorthStar 3D mapping system.
Pharmaceutical distributor Sigma Healthcare (ASX:SIG) rose 47.4% in November after the ACCC granted its merger with privately listed discount pharmacy chain Chemist Warehouse.
The union will combine SIG’s 400-plus pharmacies, under brands Discount Drug Store and Amcal, and its wholesale distribution business (servicing more than 4000 chemists) with Chemist Warehouse’s 600 franchised outlets.
Medical imaging stock Singular Health Group Ltd (ASX:SHG) was up 34.1% in November after announcing it had signed a memorandum of understanding (MOU) with Provider Network Solutions (PNS) in the US to collaborate on a technical proof of concept and commercial pilot and had undertaken a $3.7 million capital raise.
Healthcare giant ProMedicus (ASX:PME) posted a 28.8% gain in November after inking a couple of big contracts.
ProMedicus signed a $330m, 10-year deal with Trinity Health to replace its legacy imaging system with PME’s cloud-based Visage 7 platform across 93 hospitals, expanding the company’s presence in North America.
The company also announced in November its wholly-owned US subsidiary Visage Imaging Inc had signed an additional $24m, five-year contract with NYU Langone Health.
ProMedicus said the contract had been extended to “full stack”, with the addition of Visage 7 Open Archive to the Visage 7 Viewer and Visage 7 Workflow.
At Stockhead, we tell it like it is. While Paradigm Biopharmaceuticals, Imricor Medical Systems and Singular Health Group are Stockhead advertisers, the companies did not sponsor this article.
Health & Biotech
Health & Biotech
Health & Biotech
